TickerFacts.

Company research / NTRB

NutriBand Inc. (NTRB)

Also trades as NTRBW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001676047 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Jan 31

For the year ended 2026-01-31, NutriBand Inc. reported revenue of $2.04M. Revenue fell 4.8% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $1.62M.

Key ratios (year ended 2026-01-31)

27.8%
Gross margin (computed)
-408.4%
Operating margin
-404.1%
Net margin
-123.2%
Return on year-end equity
-4.8%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-23

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31		2026-01-312025-01-312024-01-312023-01-312022-01-312021-01-312020-01-312019-01-312018-01-312017-01-31
Revenue$1.62M$2.04M$2.14M$2.09M$2.08M$1.42M$943.7K$370.6K$245.3Kn/an/a
Cost of Revenue$1.08M$1.47M$1.40M$1.22M$1.33M$917.8K$627.4K$549.1K$288.3Kn/an/a
Gross Profit (computed)$536.1K$566.3K$743.3K$862.1K$750.4K$504.3K$316.3K-$178.5K-$43.0Kn/an/a
R&D Expense$1.21M$1.89M$3.12M$1.96M$982.2K$411.4Kn/an/an/an/an/a
Operating Income-$7.05M-$8.32M-$10.28M-$4.87M-$4.48M-$6.11M-$2.60M-$1.97M-$3.33M-$2.67M-$151.3K
Depreciation & Amortization$146.4K$193.8K$285.1K$287.7K$330.1K$308.7K$160.1K$72.2K$37.0Kn/an/a
EBITDA-$6.90M-$8.12M-$10.00M-$4.58M-$4.15M-$5.80M-$2.44M-$1.90M-$3.29Mn/an/a
Net Income-$6.96M-$8.23M-$10.48M-$5.49M-$4.48M-$6.18M-$2.93M-$2.72M-$3.33M-$2.67M-$151.3K
EPS (Diluted)n/a-$2.58-$0.99-$0.69-$0.53-$0.80n/an/an/an/an/a
Total Assets$6.29M$7.55M$7.47M$7.52M$9.46M$12.74M$9.93M$2.20M$2.81M$164.9K$37.7K
Total Liabilities$964.4K$868.4K$1.04M$1.08M$883.4K$880.4K$2.82M$2.02Mn/an/a$14.6K
Long-Term Debtn/an/an/an/an/an/an/an/an/a$1.8K$1.6K
Shareholders' Equity$5.33M$6.68M$6.43M$6.44M$8.57M$11.86M$7.11M$175.4K$2.40M$121.5K$23.1K
Cash & Equivalents$3.42M$4.57M$4.31M$492.9K$1.99M$4.89M$152.0K$10.2K$474.7Kn/a$27.1K
Operating Cash Flow-$3.63M-$5.13M-$4.63M-$3.53M-$2.99M-$2.81M-$297.1K-$894.5K-$1.11M-$92.9K-$147.9K
Capital Expendituresn/a$5.3K$92.0K$51.8K$79.3K$81.6Kn/an/a$4.2Kn/an/a
Free Cash Flown/a-$5.14M-$4.72M-$3.58M-$3.07M-$2.89Mn/an/a-$1.11Mn/an/a
Shares Outstanding12.16M12.16M11.07M8.86M7.83M9.15M6.26M5.44M5.42M20.88M15.57M
Weighted Average Diluted Sharesn/a11.64M10.61M7.95M8.46M7.93M5.77Mn/an/an/an/a
EPS (Basic)n/a-$2.58-$0.99-$0.69-$0.53-$0.80-$0.51n/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView